Upgrade to SI Premium - Free Trial

bluebird bio (BLUE) Falls 5% on Juno Clinical Hold

November 23, 2016 8:42 AM
bluebird bio (NASDAQ: BLUE) is trading down after peer Juno Therapeutics, Inc. (Nasdaq: JUNO) announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Trader Talk

Next Articles